eli lilly clinical trials tirzepatide Lilly's Zepbound tops Wegovy for weight loss in head-to-head trial ESC 2024: Retatrutide improves lipid

GLP-1 therapies are also being folded more and more into individual care plans so they can improve effectiveness and better clinical results

Second, the hunger strikes so hard that you have very little control over what food you choose to consume

A diet rich in legumes, oats, flax, chia, and cruciferous vegetables f eeds beneficial gut bacteria, increasing short-chain fatty acids (SCFAs) that stimulate intestinal L-cells for native GLP-1 release (News-Medical)

It modulates NMDA receptors, potentially reducing excitotoxicity and supporting neuroprotective functions relevant to muscle-nerve communication during recovery